CYTOKINETICS INC CYTK
COM NEW · Common Stock · CUSIP 23282W605 · ISIN US23282W6057
Company in South San Francisco, United States
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersSouth San Francisco, CA
- Founded1997
- Websitecytokinetics.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($4.4m this quarter). Holder counts are more reliable. Shares outstanding: 122.3m as of 2025-11-03, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $63.53. Options: 30 managers hold calls ($479.2m notional), 22 hold puts ($117.6m).
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 279 |
| Q4 2022 | 279 |
| Q1 2023 | 265 |
| Q2 2023 | 255 |
| Q3 2023 | 252 |
| Q4 2023 | 349 |
| Q1 2024 | 389 |
| Q2 2024 | 345 |
| Q3 2024 | 349 |
| Q4 2024 | 348 |
| Q1 2025 | 358 |
| Q2 2025 | 314 |
| Q3 2025 | 382 |
| Q4 2025 | 432 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2024 | 227 | 181 |
| Q2 2024 | 196 | 177 |
| Q3 2024 | 187 | 138 |
| Q4 2024 | 146 | 183 |
| Q1 2025 | 193 | 152 |
| Q2 2025 | 171 | 173 |
| Q3 2025 | 222 | 128 |
| Q4 2025 | 227 | 179 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q1 2025 | $183.6m | $45.7m | 0.25 |
| Q2 2025 | $217.5m | $45.9m | 0.21 |
| Q3 2025 | $363.0m | $87.6m | 0.24 |
| Q4 2025 | $479.2m | $117.6m | 0.25 |
Biggest buyers
| T. Rowe Price Investment Management, Inc. | Added | +8.0m |
| BlackRock, Inc. | Added | +869.4k |
| GOLDMAN SACHS GROUP INC | Added | +737.0k |
| WELLINGTON MANAGEMENT GROUP LLP | Added | +528.5k |
| Qube Research & Technologies Ltd | Added | +528.2k |
| FEDERATED HERMES, INC. | Added | +457.9k |
| Affinity Asset Advisors, LLC | Added | +450.0k |
| ExodusPoint Capital Management, LP | New | +343.1k |
| BNP PARIBAS FINANCIAL MARKETS | Added | +332.4k |
| EVENTIDE ASSET MANAGEMENT, LLC | Added | +309.5k |
Biggest sellers
| JPMORGAN CHASE & CO | Reduced | -1.7m |
| Deep Track Capital, LP | Reduced | -963.0k |
| Vestal Point Capital, LP | Sold out | -725.0k |
| UBS Group AG | Reduced | -671.8k |
| Point72 Asset Management, L.P. | Sold out | -471.5k |
| Aberdeen Group plc | Reduced | -444.8k |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | Reduced | -444.5k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | -436.7k |
| Pictet Asset Management Holding SA | Reduced | -388.0k |
| Polar Capital Holdings Plc | Reduced | -360.3k |
Biggest calls
| ARMISTICE CAPITAL, LLC | Added | $95.3m1.5m shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Added | $90.7m1.4m shares |
| GROUP ONE TRADING LLC | Reduced | $55.0m865.9k shares |
| JANE STREET GROUP, LLC | Added | $53.4m840.5k shares |
| Integral Health Asset Management, LLC | Reduced | $31.8m500.0k shares |
| Caption Management, LLC | Added | $30.9m486.3k shares |
| Balyasny Asset Management L.P. | Reduced | $22.8m358.5k shares |
| Ikarian Capital, LLC | Added | $18.5m290.9k shares |
| NOMURA HOLDINGS INC | Added | $16.2m254.2k shares |
| BARCLAYS PLC | Reduced | $8.4m132.2k shares |
Biggest puts
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Added | $44.5m700.6k shares |
| CITADEL ADVISORS LLC | Added | $22.5m354.4k shares |
| GOLDMAN SACHS GROUP INC | New | $11.8m186.4k shares |
| GROUP ONE TRADING LLC | Reduced | $7.6m118.9k shares |
| NOMURA HOLDINGS INC | Added | $6.8m107.2k shares |
| CITIGROUP INC | Added | $3.8m60.0k shares |
| JANE STREET GROUP, LLC | Reduced | $3.4m53.5k shares |
| SIMPLEX TRADING, LLC | Reduced | $2.8m43.7k shares |
| BARCLAYS PLC | New | $2.2m35.0k shares |
| Polar Capital Holdings Plc | New | $2.1m33.0k shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| T. Rowe Price Investment Management, Inc. 13G · institution -1.5 pts · filed 2026-02-17 | 14.5% |
| VANGUARD CAPITAL MANAGEMENT LLC 13G · institution new · filed 2026-04-29 | 5.2% |
| WELLINGTON MANAGEMENT GROUP LLP 13G · institution filed 2026-08-13 | 5.1% |
Fell to 5% or below in the last year: FMR LLC (3.9%, 2026-07-08), VANGUARD GROUP INC (0.0%, 2026-03-26; now reported by VANGUARD CAPITAL MANAGEMENT LLC)
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2024 | 0 | — | 3 | $11.0m | $11.0m |
| Q2 2024 | 0 | — | 7 | $8.5m | $8.5m |
| Q3 2024 | 0 | — | 4 | $7.6m | $7.6m |
| Q4 2024 | 0 | — | 4 | $3.7m | $3.7m |
| Q1 2025 | 0 | — | 4 | $8.2m | $5.5m |
| Q2 2025 | 0 | — | 8 | $2.9m | $2.9m |
| Q3 2025 | 0 | — | 4 | $2.5m | $2.5m |
| Q4 2025 | 0 | — | 8 | $10.6m | $10.6m |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-12-29 | Callos Andrew EVP, Chief Commercial Officer | Sold plan | $113.0k1.8k shares |
| 2025-12-22 | WIERENGA WENDELL Director | Sold plan | $1.3m20.0k shares |
| 2025-12-16 | Malik Fady Ibraham EVP Research & Development | Sold plan | $134.7k2.2k shares |
| 2025-12-08 | Callos Andrew EVP, Chief Commercial Officer | Sold plan | $68.7k1.0k shares |
| 2025-12-05 | Callos Andrew EVP, Chief Commercial Officer | Sold plan | $3.5m52.5k shares |
| 2025-12-02 | HENDERSON JOHN T Director | Sold plan | $559.1k8.8k shares |
| 2025-12-02 | Malik Fady Ibraham EVP Research & Development | Sold plan | $140.6k2.2k shares |
| 2025-12-01 | Kaye Edward M. MD Director | Sold plan | $1.9m28.1k shares |
| 2025-12-01 | Harrington Robert Arthur Director | Sold plan | $143.6k2.1k shares |
| 2025-11-19 | PARSHALL B LYNNE Director | Sold plan | $323.6k5.0k shares |
| 2025-11-18 | Malik Fady Ibraham EVP Research & Development | Sold plan | $146.2k2.2k shares |
| 2025-11-11 | Kaye Edward M. MD Director | Sold plan | $336.8k5.2k shares |
| 2025-11-04 | Malik Fady Ibraham EVP Research & Development | Sold plan | $136.7k2.3k shares |
| 2025-10-30 | Blum Robert I President & CEO, director | Sold plan | $314.3k5.0k shares |
| 2025-10-27 | WIERENGA WENDELL Director | Sold plan | $256.7k4.4k shares |
| 2025-10-21 | Malik Fady Ibraham EVP Research & Development | Sold plan | $122.6k2.1k shares |
| 2025-10-16 | Blum Robert I President & CEO, director | Sold plan | $300.1k5.0k shares |
| 2025-10-07 | Malik Fady Ibraham EVP Research & Development | Sold plan | $121.1k2.0k shares |
| 2025-10-06 | Kaye Edward M. MD Director | Sold plan | $405.4k6.8k shares |
| 2025-10-01 | Blum Robert I President & CEO, director | Sold plan | $275.2k5.0k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| T. Rowe Price Investment Management, Inc. 0.68% of their portfolio | 27.1m $1.7bn | Added +8.0m |
| BlackRock, Inc. 0.02% of their portfolio | 16.4m $1.0bn | Added +869.4k |
| FMR LLC 0.04% of their portfolio | 12.8m $813.8m | Reduced -283.9k |
| VANGUARD GROUP INC 0.01% of their portfolio | 12.0m $765.5m | Added +191.3k |
| WELLINGTON MANAGEMENT GROUP LLP 0.09% of their portfolio | 7.9m $504.3m | Added +528.5k |
| STATE STREET CORP 0.01% of their portfolio | 5.8m $370.1m | Added +208.0k |
| Deep Track Capital, LP 4.84% of their portfolio | 3.3m $212.0m | Reduced -963.0k |
| GEODE CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 3.1m $194.2m | Added +15.8k |
| BANK OF AMERICA CORP /DE/ 0.01% of their portfolio | 2.9m $186.9m | Reduced -120.6k |
| RTW INVESTMENTS, LP 1.73% of their portfolio | 2.7m $172.9m | Unchanged |
| Polar Capital Holdings Plc 0.70% of their portfolio | 2.4m $153.9m | Reduced -360.3k |
| GOLDMAN SACHS GROUP INC 0.02% of their portfolio | 2.4m $150.7m | Added +737.0k |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.01% of their portfolio | 1.9m $122.6m | Reduced -436.7k |
| Woodline Partners LP 0.41% of their portfolio | 1.6m $104.7m | Added +703 |
| JPMORGAN CHASE & CO 0.01% of their portfolio | 1.4m $89.8m | Reduced -1.7m |
| Integral Health Asset Management, LLC 4.51% of their portfolio | 1.4m $89.0m | Unchanged |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.01% of their portfolio | 1.4m $87.9m | Added +9.6k |
| NORTHERN TRUST CORP 0.01% of their portfolio | 1.4m $87.7m | Reduced -26.0k |
| MORGAN STANLEY 0.00% of their portfolio | 1.3m $80.4m | Reduced -255.9k |
| Capital International Investors 0.01% of their portfolio | 1.2m $74.9m | Unchanged |
| CITADEL ADVISORS LLC 0.05% of their portfolio | 1.2m $73.9m | Reduced -223.1k |
| UBS Group AG 0.01% of their portfolio | 1.1m $71.9m | Reduced -671.8k |
| ARMISTICE CAPITAL, LLC 1.54% of their portfolio | 992.8k $63.1m | Reduced -204.1k |
| Royalty Pharma Sub-Manager, LLC 36.36% of their portfolio | 980.4k $62.3m | First filing |
| PRINCIPAL FINANCIAL GROUP INC 0.03% of their portfolio | 976.9k $62.1m | Reduced -197.6k |
| Frazier Life Sciences Management, L.P. 1.60% of their portfolio | 934.6k $59.4m | Added +44.2k |
| Bank of New York Mellon Corp 0.01% of their portfolio | 854.3k $54.3m | Reduced -14.9k |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.06% of their portfolio | 827.9k $52.6m | Added +42.9k |
| Fisher Asset Management, LLC 0.02% of their portfolio | 822.9k $52.3m | Added +61.3k |
| NORGES BANK 0.01% of their portfolio | 807.1k $51.3m | Not comparable |
| Affinity Asset Advisors, LLC 3.65% of their portfolio | 800.0k $50.8m | Added +450.0k |
| Pictet Asset Management Holding SA 0.05% of their portfolio | 757.6k $48.0m | Reduced -388.0k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.07% of their portfolio | 753.6k $47.9m | Reduced -264.2k |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.22% of their portfolio | 748.0k $47.5m | Reduced -444.5k |
| BROWN ADVISORY INC 0.06% of their portfolio | 731.2k $46.5m | Reduced -181.0k |
| Melqart Asset Management (UK) Ltd 3.96% of their portfolio | 622.9k $39.6m | Reduced -160.9k |
| BNP PARIBAS FINANCIAL MARKETS 0.02% of their portfolio | 579.9k $36.8m | Added +332.4k |
| AMERIPRISE FINANCIAL INC 0.01% of their portfolio | 545.8k $34.7m | Reduced -18.7k |
| TD Asset Management Inc 0.03% of their portfolio | 544.0k $34.6m | Reduced -127.8k |
| ADAR1 Capital Management, LLC 2.57% of their portfolio | 540.2k $34.3m | Added +21.2k |
| Qube Research & Technologies Ltd 0.05% of their portfolio | 537.3k $34.1m | Added +528.2k |
| FEDERATED HERMES, INC. 0.05% of their portfolio | 483.7k $30.7m | Added +457.9k |
| Aberdeen Group plc 0.05% of their portfolio | 483.1k $30.7m | Reduced -444.8k |
| EVENTIDE ASSET MANAGEMENT, LLC 0.48% of their portfolio | 479.6k $30.5m | Added +309.5k |
| GW&K Investment Management, LLC 0.26% of their portfolio | 472.4k $30.0m | Added +291.7k |
| Foresite Capital Management IV, LLC 12.68% of their portfolio | 458.3k $29.1m | Unchanged |
| AMERICAN CENTURY COMPANIES INC 0.01% of their portfolio | 443.9k $28.2m | Added +14.7k |
| ALLIANCEBERNSTEIN L.P. 0.01% of their portfolio | 413.0k $26.2m | Added +177.6k |
| FRANKLIN RESOURCES INC 0.01% of their portfolio | 410.0k $26.1m | Added +265 |
| GROUP ONE TRADING LLC 0.77% of their portfolio | 407.3k $25.9m | Added +219.3k |
| Sarissa Capital Management LP 11.30% of their portfolio | 396.4k $25.2m | Reduced -192.0k |
| GILDER GAGNON HOWE & CO LLC 0.26% of their portfolio | 385.8k $24.5m | Reduced -3.2k |
| DAFNA Capital Management LLC 5.48% of their portfolio | 371.0k $23.6m | Reduced -23.9k |
| Nuveen, LLC 0.01% of their portfolio | 369.3k $23.5m | Reduced -1.6k |
| E. Ohman J:or Asset Management AB 0.54% of their portfolio | 363.0k $23.1m | Reduced -44.1k |
| RHUMBLINE ADVISERS 0.02% of their portfolio | 357.0k $22.7m | Reduced -28.8k |
| BARCLAYS PLC 0.01% of their portfolio | 343.5k $21.8m | Reduced -54.6k |
| ExodusPoint Capital Management, LP 0.24% of their portfolio | 343.1k $21.8m | New |
| GSK plc 2.71% of their portfolio | 340.4k $21.6m | First filing |
| MARSHALL WACE, LLP 0.02% of their portfolio | 337.0k $21.4m | Added +158.1k |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.01% of their portfolio | 327.2k $20.8m | Reduced -169.5k |
| First Turn Management, LLC 2.36% of their portfolio | 325.7k $20.7m | Added +70.9k |
| Logos Global Management LP 1.27% of their portfolio | 300.0k $19.1m | New |
| JANE STREET GROUP, LLC 0.02% of their portfolio | 284.1k $18.1m | New |
| Susquehanna Portfolio Strategies, LLC 0.27% of their portfolio | 278.4k $17.7m | Unchanged |
| TWO SIGMA INVESTMENTS, LP 0.03% of their portfolio | 274.0k $17.4m | New |
| Catalio Capital Management, LP 2.90% of their portfolio | 258.4k $16.4m | Reduced -193.2k |
| JANUS HENDERSON GROUP PLC 0.01% of their portfolio | 256.2k $16.3m | Added +206.6k |
| AQR CAPITAL MANAGEMENT LLC 0.01% of their portfolio | 236.9k $14.8m | Reduced -276.4k |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.00% of their portfolio | 235.0k $14.9m | Reduced -3.3k |
| MILLENNIUM MANAGEMENT LLC 0.01% of their portfolio | 225.5k $14.3m | Reduced -117.1k |
| Swiss National Bank 0.01% of their portfolio | 224.2k $14.2m | Added +4.3k |
| Handelsbanken Fonder AB 0.04% of their portfolio | 205.8k $13.1m | Reduced -28.7k |
| Invesco Ltd. 0.00% of their portfolio | 204.9k $13.0m | Added +47.6k |
| Mirador Capital Partners LP 1.73% of their portfolio | 198.6k $12.6m | Added +1.2k |
| Rosalind Advisors, Inc. 4.52% of their portfolio | 195.0k $12.4m | Reduced -205.0k |
| PINNACLE ASSOCIATES LTD 0.16% of their portfolio | 191.0k $12.1m | Reduced -10.5k |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.01% of their portfolio | 190.8k $12.0m | Reduced -1.1k |
| SEGALL BRYANT & HAMILL, LLC 0.16% of their portfolio | 189.5k $12.0m | Added +8.5k |
| California Public Employees Retirement System 0.01% of their portfolio | 189.4k $12.0m | Added +39.0k |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 175.8k $11.2m | Added +10.2k |
| Hudson Bay Capital Management LP 0.06% of their portfolio | 175.3k $11.1m | Reduced -6.8k |
| TWO SIGMA ADVISERS, LP 0.02% of their portfolio | 174.7k $11.1m | New |
| Ikarian Capital, LLC 1.42% of their portfolio | 172.7k $11.0m | Reduced -50.0k |
| RENAISSANCE TECHNOLOGIES LLC 0.02% of their portfolio | 172.1k $10.9m | Reduced -117.9k |
| Legal & General Group Plc 0.00% of their portfolio | 168.6k $10.7m | Reduced -11.1k |
| Checkpoint Capital L.P. 3.36% of their portfolio | 166.8k $10.6m | Added +129.2k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 161.6k $10.3m | Added +64.1k |
| STEMPOINT CAPITAL LP 1.60% of their portfolio | 147.0k $9.3m | New |
| Retirement Systems of Alabama 0.03% of their portfolio | 146.7k $9.3m | Added +2.0k |
| Candriam S.C.A. 0.05% of their portfolio | 146.6k $9.3m | New |
| ROYCE & ASSOCIATES LP 0.09% of their portfolio | 144.4k $9.2m | Added +44.3k |
| Russell Investments Group, Ltd. 0.01% of their portfolio | 137.7k $8.7m | Added +17.8k |
| Hood River Capital Management LLC 0.10% of their portfolio | 137.6k $8.7m | New |
| FIRST TRUST ADVISORS LP 0.01% of their portfolio | 127.5k $8.1m | New |
| Exome Asset Management LLC 3.92% of their portfolio | 124.7k $7.9m | Reduced -17.7k |
| READYSTATE ASSET MANAGEMENT LP 0.34% of their portfolio | 122.7k $7.8m | Reduced -19.8k |
| MetLife Investment Management, LLC 0.04% of their portfolio | 121.9k $7.7m | Reduced -5.7k |
| D. E. Shaw & Co., Inc. 0.01% of their portfolio | 119.2k $7.6m | Added +105.6k |
| HighVista Strategies LLC 1.87% of their portfolio | 114.6k $7.3m | Reduced -18.4k |